UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015457
Receipt No. R000017971
Official scientific title of the study A Japanese prospective multi-center study of the effectiveness and safety of influenza vaccine.
Date of disclosure of the study information 2014/10/20
Last modified on 2016/04/27 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Japanese prospective multi-center study of the effectiveness and safety of influenza vaccine.
Title of the study (Brief title) FLU STUDY'14-'15/JPA(I)
Region
Japan

Condition
Condition influenza
Classification by specialty
Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluation of the effectiveness and the safety of influenza vaccine.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Incidence of influenza illness
Adverse event of vaccination
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Not applicable
Key exclusion criteria Not applicable
Target sample size

Research contact person
Name of lead principal investigator Norio Iwaki
Organization Japan Physicians Association
Division name Influenza study group
Address 1-2-2 Hitotsubashi Chiyoda-ku, Tokyo-to, Japan
TEL 03-5224-6110
Email jpa@oregano.ocn.ne.jp

Public contact
Name of contact person Naoki Kawai
Organization Japan Physicians Association
Division name Influenza study group
Address 1-2-2 Hitotsubashi Chiyoda-ku, Tokyo-to, Japan
TEL 03-5224-6110
Homepage URL
Email jpa@oregano.ocn.ne.jp

Sponsor
Institute Influenza study group, Japan Physicians Association
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 09 Month 29 Day
Anticipated trial start date
2014 Year 10 Month 01 Day
Last follow-up date
2015 Year 05 Month 31 Day
Date of closure to data entry
2015 Year 05 Month 31 Day
Date trial data considered complete
2015 Year 06 Month 30 Day
Date analysis concluded
2015 Year 07 Month 20 Day

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results http://www.japha.jp
Results The efficacy and the safety of the influenza vaccine.
Other related information Register influenza vaccine recipients group and the non-vaccinated group.
Compare a number of affected individuals with vaccine recipients and non-vaccinated.

Management information
Registered date
2014 Year 10 Month 17 Day
Last modified on
2016 Year 04 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017971